Skip to main content
PTGX logo

PTGX · Protagonist Therapeutics, Inc · Analyst Estimates

Track PTGX — free
$127.16 +2.49 (+2.00%) At close · Nov 18 Q4 2020 earnings call transcript
Market Cap
$8.30B
Shares
65.27M
Volume · Nov 18 433.18K Avg daily vol (3M) 666.83K

Analyst Estimates

Compare analyst forecasts for Protagonist Therapeutics, Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-17 14:46 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
3.04
5.09
7.30
12
4.77
4.67
4.79
4.75
0
3
3
3
Revenue
USD
Publication date not stated
420.00M
565.18M
674.50M
13
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.17
0.35
7.60
12
-0.099
-0.14
-0.20
-0.14
0
2
0
1
Revenue
USD
Publication date not stated
116.00M
235.79M
797.90M
13
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.84
-0.22
1.88
10
-0.50
-0.43
-0.43
-0.39
1
3
0
0
Revenue
USD
Publication date not stated
2.65M
48.50M
167.90M
10
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.35
0.36
1.85
4
-0.095
-0.13
-0.13
0.026
0
0
0
0
Revenue
USD
Publication date not stated
16.10M
58.33M
191.00M
5
— — — — — — — —
Key facts CIK 1377121 CUSIP 74366E102 13F (30d) 382 filings 356 filers Visit website Investor relations